Show simple item record

dc.contributor.authorVidovic, Dejan
dc.date.accessioned2019-11-28T15:37:02Z
dc.date.available2019-11-28T15:37:02Z
dc.date.issued2019-11-28T15:37:02Z
dc.identifier.urihttp://hdl.handle.net/10222/76680
dc.description.abstractTriple-negative breast cancer (TNBC) patients face poor prognoses, possibly due to the presence of highly tumorigenic cancer stem cells (CSCs) within their tumors. The search for possible CSC targets is limited, but may be aided by identification of novel unstudied factors that regulate stemness, such as long noncoding RNAs (lncRNAs), which are often highly overexpressed in cancer making them attractive therapeutic targets. Here, we identify oncogenic LINC00284 as highly enriched in TNBC and CSCs, and for the first time, target this CSC-enriched lncRNA in vivo to slow tumor growth and kill CSC populations. We also functionally interrogate LINC00284 to identify its yet unknown mechanism of action in cancer, revealing a complex mechanism involved in gene expression regulation through interactions with multifunctional nuclear protein SND1.en_US
dc.language.isoen_USen_US
dc.subjectCancer biologyen_US
dc.subjectBreast canceren_US
dc.subjectLncRNAen_US
dc.titleDISCOVERY AND CHARACTERIZATION OF A CANCER STEM CELL-ENRICHED LONG NON-CODING RNA IN TRIPLE-NEGATIVE BREAST CANCERen_US
dc.date.defence2018-07-06
dc.contributor.departmentDepartment of Pathologyen_US
dc.contributor.degreeMaster of Scienceen_US
dc.contributor.external-examinerDr. Zhenyu Chengen_US
dc.contributor.graduate-coordinatorDr. Wenda Greeren_US
dc.contributor.thesis-readerDr. Wenda Greeren_US
dc.contributor.thesis-readerDr. Shashi Gujaren_US
dc.contributor.thesis-readerDr. Roy Duncanen_US
dc.contributor.thesis-supervisorDr. Paola Marcatoen_US
dc.contributor.ethics-approvalReceiveden_US
dc.contributor.manuscriptsNot Applicableen_US
dc.contributor.copyright-releaseNot Applicableen_US
 Find Full text

Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record